David Kuczer

新着
26年の経験
所在地：オーストリア, ウィーン
クリニック：Amethyst Radiotherapy Austria 放射線治療センター
Dr. David Kuczer is a specialist in radio-oncology with many years of experience in cancer diagnosis and treatment. He offers fast access to precise radiotherapy based on current scientific standards.

He is a member of the Cancer Center at the Vienna Private Clinic. He presents each patient to the in-house tumor board. This allows an interdisciplinary discussion by an internationally renowned team and helps select the best treatment.

All radiation treatments are provided in close cooperation with Amethyst Radiotherapy at the Vienna Private Clinic.
続きを読む

新着

パッケージ価格$7,000.76

Christoph Zielinski

5 優秀 • 4 レビュー
44年の経験
認定:
所在地：オーストリア, ウィーン
クリニック：
4.7
Wiener Privatklinik
ツィエリンスキー教授はオーストリア最大の腫瘍科を率い、ウィーン癌センターにおいてがんの個別化治療を先駆的に推進してきました。
- 44年の経験腫瘍内科学および免疫療法を専門とする
- ウィーン総合がんセンター（CCC）を設立
- 中央ヨーロッパ協同腫瘍学グループ元会長
- 主要腫瘍学専門誌に多数の論文を発表
- ウィーナー・プリヴァートクリニク国際腫瘍センター医療部長
続きを読む

5 優秀

4 レビュー

診察

お問い合わせください

Harald Rosen

新着
41年の経験
認定:
所在地：オーストリア, ウィーン
クリニック：
4.7
Wiener Privatklinik
41年の経験低侵襲消化器内視鏡手術を専門とし、ウィーナー・プリファートクリニックにて外科的精度と内科的専門知識を融合させた診療を行っています。
- 複雑症例における診断・治療的内視鏡検査の専門家
- オーストリアにおける現代的内視鏡外科手技の先駆者
- 迅速な回復を目指した低侵襲治療に注力
- 消化器悪性腫瘍および肝疾患を専門とする
続きを読む

新着

診察

お問い合わせください

Wolfgang Köstler

5 優秀 • 3 レビュー
22年の経験
所在地：オーストリア, ウィーン
クリニック：
4.7
Wiener Privatklinik
Univ. Prof. Dr. ウォルフガング・ケストラーは、オーストリアの著名な医学的腫瘍学者および内科医であり、乳がん、婦人科悪性腫瘍、および標的がん治療の専門知識で国際的に認められています。臨床、学術、研究の経験が20年以上にわたり、彼はオーストリアにおける個別化がん治療の最前線の権威の一人となりました。
彼はウィーン大学で医学を学び、1990年代に卒業し、その後ウィーン医科大学で内科および医学的腫瘍学のレジデンシーを修了しました。キャリアの初期には、彼は先進的な腫瘍学者と共に標的療法と個別化医療の開発に従事し、これは後の彼の多くの研究に影響を与える分野となりました。
   1990年代 – ウィーン総合病院（AKH）での内科および腫瘍学の研究およびレジデンシーを修了しました。
   2000年代 – 固形腫瘍腫瘍学に特化し、乳がんや婦人科がんに焦点を当て、標的療法に関する初期の臨床試験に貢献しました。
   2010年代 – ウィーン医科大学の准教授および腫瘍学の臨床部門の副主任に任命され、分子腫瘍学の推進に貢献しました。
   現在 – ウィーン私立クリニックで上級コンサルタントとして勤務し、ウィーン医科大学での学術活動を続け、個別化された全身がん治療、免疫療法、および転位がん研究に注力しています。
ケストラー教授の研究関心には、バイオマーカーの開発、腫瘍生物学、および標的薬剤への耐性メカニズムが含まれており、正確な腫瘍学における新しい治療戦略の設計に貢献しています。彼の科学研究は主要な国際雑誌に掲載されており、彼はヨーロッパの腫瘍学ネットワークに積極的に参加し続けています。
診断の正確さ、臨床的共感、革新的な考え方で知られるケストラー教授は、科学的進歩と慈悲深い患者ケアを組み合わせた個別化がん医学の未来を体現しています。
続きを読む

5 優秀

3 レビュー

診察

お問い合わせください

Bookimed洞察：オーストリアのトップ膀胱癌専門家（2026）

Bookimedはオーストリアの膀胱癌治療リクエスト53699件を調整し、4名のトップ評価専門家と協力しています。この表の医師は国際的資格、臨床専門知識、患者の結果に基づいて選ばれています。2026年ランキングは実際の患者ケースとパートナークリニックの現行プログラムからの検証済みデータを使用して形成されています

順位	医師	経験	適合する方	特色	クリニックと所在地	診察
#1	Christoph Zielinski	44年の経験	進行膀胱癌免疫療法	40年以上の腫瘍学経験を持つ個別化がん治療のパイオニア。ウィーン包括的がんセンター（CCC Vienna）を設立し、国際的な免疫腫瘍学研究を主導。元CECOG会長。	Wiener Privatklinik オーストリア	お問い合わせください
#2	Harald Rosen	41年の経験	複雑な消化管悪性腫瘍	低侵襲内視鏡手術の専門家であり、外科的精度と内科的洞察を融合させている。より短い回復期間を実現する現代的な手技を先駆けて確立した。	Wiener Privatklinik オーストリア	お問い合わせください

FAQ

これらのFAQはBookimedを通じて医療支援を求める実際の患者からのものです。回答は経験豊富な医療コーディネーターと信頼できるクリニック代表者が行います。

What are the main treatment options for bladder cancer offered in Austria?

Austria offers advanced bladder cancer treatments through a multidisciplinary approach focused in Vienna. Patients access transurethral resection (TURBT), radical cystectomy with robotic assistance, and specialized urinary reconstruction. Innovative options like Actinium-225 therapy, immunotherapy with Keytruda, and particle radiation at MedAustron provide cutting-edge systemic care.

Surgical interventions: Surgeons perform TURBT for early stages and radical cystectomy for muscle-invasive cases.
Urinary reconstruction: Post-cystectomy options include building neobladders or ileal conduits from intestinal segments.
Advanced therapies: Clinics provide Actinium-225 therapy, HIPEC, and immunotherapy for complex or metastatic cases.
Intravesical treatment: Bacillus Calmette-Guerin (BCG) and chemotherapy are delivered directly into the bladder.

Bookimed Expert Insight: While many centers offer standard oncology, Vienna is a global hub for physician-led innovation. Specialists like Dr. Christoph Zielinski and Dr. Wolfgang Kostler at Wiener Privatklinik bridge the gap between academic research and private care. These experts often manage the same tumor boards at the massive Vienna General Hospital (AKH), which serves over 590,000 patients annually. Choosing a private setting in Vienna allows for faster 4–8 week wait times while maintaining access to these top-tier university professors.

Patient Consensus: Patients emphasize that seeking a second opinion early often reveals bladder-sparing options instead of full removal. Those undergoing BCG therapy note it is effective for preserving the bladder but suggest preparing for temporary flu-like symptoms.

How do Austrian urologic surgeons qualify to treat bladder cancer, and what safety benchmarks apply?

Austrian urologic surgeons qualify through a six-year medical degree follow by a six-year residency. They must pass rigorous board exams to earn Facharzt fur Urologie certification. Many obtain the Fellow of the European Board of Urology (FEBU) credential. Safety follows strict European Association of Urology (EAU) clinical guidelines.

Residency structure: Training includes four years in urology plus two years in surgery or medicine.
Oncology fellowships: Specialists often complete two-year urologic oncology fellowships at major university hospitals.
Surgical benchmarks: Surgeons must perform complete tumor resection with detrusor muscle biopsy for staging.
Quality monitoring: National registries track outcomes and maintain five-year survival rates around 75% to 80%.

Bookimed Expert Insight: Data shows a clear link between specialist volume and patient safety in Austria. Academic centers like Vienna General Hospital (AKH) handle nearly 600,000 patients annually. Choosing a surgeon who performs over 50 cystectomies yearly significantly improves survival rates compared to low-volume practitioners. Elite clinics like Wiener Privatklinik also use interdisciplinary tumor boards for every oncology case to ensure safety.

Patient Consensus: Patients emphasize the importance of verifying a surgeon's specialty certification through the Austrian Medical Chamber. They note that choosing university hospitals in Vienna or Graz ensures access to the highest surgical volumes.

Is robotic or minimally invasive cystectomy widely available in Austria, and what are the typical recovery times?

Robotic and minimally invasive cystectomy is widely available in Austria at specialized centers in Vienna and Linz. Surgeons use advanced systems to perform these procedures. Patients typically experience shorter hospital stays and faster initial recovery compared to traditional open surgery protocols.

Hospital stay: Patients typically remain hospitalized for 3 to 10 days after surgery.
Initial recovery: Resuming light activities usually takes between 1 to 2 weeks post-operation.
Functional independence: Most patients reach baseline independence levels within 3 to 6 months.
Full recovery: Complete recovery from radical cystectomy generally requires 6 to 12 weeks total.
Surgical volume: Austrian medical centers perform approximately 2,100 robotic-assisted procedures every year.

Bookimed Expert Insight: While total recovery times are similar long-term, robotic surgery in Austria drastically reduces immediate post-operative stays. Vienna General Hospital (AKH) serves over 595,000 patients annually and functions as a major academic hub. Choosing high-volume centers like this is vital. Surgeons performing over 20 robotic cases yearly consistently report the best patient outcomes and fewer complications.

Patient Consensus: Patients report that robotic procedures significantly reduce blood loss and allow for walking as early as the first day. Many emphasize that while recovery is faster, temporary bowel issues remain a common milestone during the first two weeks.

What are the potential short- and long-term complications of bladder-cancer surgery in Austria and how are they managed?

Austrian specialized centers manage bladder surgery complications using Enhanced Recovery After Surgery protocols and multidisciplinary tumor boards. Short-term risks include infections and bowel dysfunction. Long-term management focuses on metabolic health and urinary function monitoring. Clinics like Wiener Privatklinik and Vienna General Hospital follow strict European Association of Urology guidelines.

Early infections: Targeted antibiotics treat urinary tract or wound infections occurring in hospital.
Bowel management: Surgeons use chewing gum and early activity to restart digestion after surgery.
Urinary function: Pelvic floor training and specialized medications manage incontinence or neobladder retention issues.
Metabolic monitoring: Lifelong blood tests track kidney function and B12 levels after reconstruction.

Bookimed Expert Insight: Data from major Viennese centers like Wiener Privatklinik and Vienna General Hospital suggests that complication rates remain below nominal values due to high physician density. With over 1,600 doctors at Vienna General Hospital alone, patients receive highly specialized surveillance. Choosing a facility with a dedicated tumor board, like those coordinated by Dr. Christoph Zielinski, ensures that metabolic and functional issues are addressed by diverse specialists before they become chronic.

Patient Consensus: Patients often find that urinary leakage and nighttime incontinence last longer than expected. Many emphasize that starting pelvic floor therapy early is the most effective way to regain control and manage daily recovery.

How long will I need to stay in Austria for bladder-cancer diagnostics and treatment, and what is the typical sequence?

Stays in Austria for bladder cancer range from 3 days for diagnostics to 6 weeks for major surgery. Initial assessments typically last 3 to 14 days. These include cystoscopy and biopsy. Major procedures like radical cystectomy require 7 days of hospitalization followed by local recovery.

Diagnostic phase: Local centers complete cystoscopy and biopsies within 3 to 7 days.
Surgical intervention: Transurethral resection (TURBT) usually requires only a 1 to 2 day hospital stay.
Advanced recovery: Radical cystectomy patients should remain in Vienna for 4 to 6 weeks.
Systemic cycles: Immunotherapy or chemotherapy protocols often span 3 to 4 months of treatment.

Bookimed Expert Insight: Patients can minimize travel by selecting hospitals like Wiener Privatklinik or Vienna General Hospital (AKH) that provide in-house histopathology. While some European labs take 10 days, these high-volume Vienna centers often speed up results. This allows patients to start intravesical BCG therapy or scheduling surgery within the same initial 2-week trip. This efficiency is critical for those traveling from outside the European Union.

Patient Consensus: Patients note that arriving one week early for staging helps avoid scheduling delays. They suggest confirming pathology turnaround times with the clinic staff to plan the flight home accurately.

Do Austrian clinics offer interpreter services, English documentation, and support for medical tourists?

Austrian clinics provide extensive interpreter services and English documentation for bladder cancer patients. Leading facilities such as Wiener Privatklinik offer personalized care in a multilingual environment. Most physicians are fluent in English. Legal requirements ensure patients receive treatment information in a language they fully understand.

Expert staff: Specialists like Dr. Christoph Zielinski manage international oncology cases in English.
Documentation: Clinics provide English versions of treatment contracts and informed consent forms.
Visa support: Hospitals frequently issue invitation letters for medical treatment to aid visa applications.
Translation services: On-site interpreters assist during registrations, diagnostic examinations, and surgical procedures.

Bookimed Expert Insight: While public hospitals like AKH Vienna serve nearly 600,000 patients annually, private clinics offer more dedicated coordination. Wiener Privatklinik provides access to professors from the Medical University of Vienna in a more boutique setting. This ensures complex bladder cancer cases receive both academic expertise and seamless logistical support.

Patient Consensus: Patients note that English documentation is standard. Some suggest hiring a private interpreter for complex real-time talks with surgeons to avoid any communication delays.

Which Austrian cities are considered best for bladder-cancer care and why?

Vienna, Graz, and Innsbruck are the premier Austrian cities for bladder cancer care. They host the nation's three Comprehensive Cancer Centers (CCC). These hubs provide interdisciplinary diagnosis and research-backed therapies. Vienna serves as the primary national center for complex robotic-assisted surgeries and advanced immunotherapy.

Vienna oncology hub: AKH Vienna and Wiener Privatklinik offer robotic cystectomy and immunotherapy.
Graz research centers: Graz Ragnitz and Medical University Graz specialize in high-volume tumor boards.
Innsbruck academic care: Innsbruck University Hospital provides advanced neobladder reconstruction and clinical trials.
Specialized precision therapy: MedAustron in nearby Wiener Neustadt delivers high-precision particle radiation therapy.

Bookimed Expert Insight: While university hospitals like AKH Vienna manage nearly 600,000 patients annually, private facilities offer significantly faster access for international cases. Clinics such as Wiener Privatklinik or Döbling Private Hospital maintain lower complication rates by utilizing University of Vienna professors in a more personalized setting. High-risk patients often benefit from this hybrid model where academic expertise meets private-sector efficiency.

Patient Consensus: Patients note that Vienna is the most efficient choice for non-EU residents to avoid university bureaucracy. Those requiring complex neobladder reconstruction emphasize traveling directly to major hubs rather than starting treatment in smaller regional cities.

オーストリアで最高の膀胱癌医師 - トップ4名の医師

オーストリアの3名のトップ専門家から見積もりを取得

David Kuczer

Christoph Zielinski

Harald Rosen

Wolfgang Köstler

完璧な医師マッチングを取得する方法

専属の Bookimedコーディネーターがお客様のニーズに合わせた完璧な外科医を見つけるお手伝いをします

適切な医師とクリニックの選び方：内部者のヒント

Bookimed洞察：オーストリアのトップ膀胱癌専門家（2026）

FAQ

What are the main treatment options for bladder cancer offered in Austria?

How do Austrian urologic surgeons qualify to treat bladder cancer, and what safety benchmarks apply?

Is robotic or minimally invasive cystectomy widely available in Austria, and what are the typical recovery times?

What are the potential short- and long-term complications of bladder-cancer surgery in Austria and how are they managed?

How long will I need to stay in Austria for bladder-cancer diagnostics and treatment, and what is the typical sequence?

Do Austrian clinics offer interpreter services, English documentation, and support for medical tourists?

Which Austrian cities are considered best for bladder-cancer care and why?